|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4439 | |
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/50 |
| (11) | Patento numeris | 2603206 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11746215.0 |
| Europos patento paraiškos padavimo data | 2011-08-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/063602 |
| Data | 2011-08-08 |
| (87) | Numeris | WO 2012/019989 |
| Data | 2012-02-16 |
| (30) | Numeris | Data | Šalis |
| 372693 P | 2010-08-11 | US |
| (72) |
CHATTERJI, Ashish, US
HUANG, Jingjun, US
KOENNINGS, Stephanie, CH
LINDENSTRUTH, Kai, DE
SANDHU, Harpreet K., US
SHAH, Navnit Hargovindas, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS |
| PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS |